This article originally appeared in Morningstar Direct Cloud and Morningstar Office Cloud.
As the opioid crisis continues to rage in the United States, publicly traded companies that manufacture, market, or sell the prescription drugs at the center of the epidemic are facing shareholder resolutions for governance reforms and improved disclosure of risks around their involvement in the making or sale of the drugs.
To view this article, become a Morningstar Basic member.
Jackie Cook does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.